My base is above the company average but that wasn't one of the 'selling' points to this job. I remember the interviewer saying, "The target bonus is 18k for the year - and it's uncapped." That implied to me that if I'm 106% of a quota, I'd earn something MORE THAN or ON TOP OF OR IN ADDITION TO 18k for the year. If what you say is true, I have ZERO incentive to move the market share of the drugs I am assigned; at most, I am to say what they tell me to say and that's all. I sure hope you're incorrect. If true, I have an excellent part-time gig I can do on the side.
But how or why would any company (Ventiv or BI in this case) think it's fair to pay nothing "extra or on top of" for above-average performance (specifically pertaining to the launch of a drug)? If I use my prior relationships to get things moving (which I've done in the past), it seems that the only people to benefit would be the BI reps... not me. From My efforts I'd be putting more money into THEIR pockets, not mine. Maybe I can work out a deal with my BI counterpart, who has no relationships in my 14-year-run territory, to slip me some cash once we (or I) hit certain milestones; if he doesn't pay up during those initial 3-4 months, it's only a matter of leveraging my relationships to make the prescriptions cease altogether. I'm not trying to sound cocky but I imagine most everyone else in my shoes would do the same.
This will be interesting, to say the least. Thanks for the post.